Oral gamma-linolenic acid in 21 patients with untreatable malignancy. An ongoing pilot open clinical trial.
Van der Merwe
C F
CF
Booyens
J
J
Katzeff
I E
IE
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D005228:Fatty Acids, Essential / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008041:Linoleic Acids; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D031665:Oenothera biennis; D010865:Pilot Projects; D010938:Plant Oils; D010997:Pleural Neoplasms / Q000188:drug therapy; D017965:gamma-Linolenic Acid
D000970:Antineoplastic Agents; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D010938:Plant Oils; C028498:evening primrose oil; D017965:gamma-Linolenic Acid